R. Centrone

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice

I. Bendit, V. Funke, C. Boquimpani, 2022, Hematology, transfusion and cell therapy.

Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene

R. C. Elias, M. Bellesso, R. Santucci, 2013, Revista brasileira de hematologia e hemoterapia.

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

J. Cortes, M. Bianchini, V. Funke, 2021, Blood advances.

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report

Milton A. F. Aranha, M. Bellesso, R. Santucci, 2019, Hematology, transfusion and cell therapy.